Form D · Biotechnology
Ingenia Therapeutics Inc.
Watertown, MA · CIK 0001796831
Offering snapshot reported Jun 21, 2024 · SEC filing
- Reported sold
- $5M Offering amount: $25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 12, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2024 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Nov 30, 2022 | Initial | $7,007,866 | No comparison | 5 | SEC filing |
| Sep 29, 2020 | Initial | $4,707,530 | No comparison | 9 | SEC filing |
| Dec 13, 2019 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-516617
Source: Form D, filed Jun 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kwang Ho Cheong | Director |
| Eric Furfine | Director |
| Sangyeul Han | Director, Executive |
| Sung Jae Kim | Director |
| Minji Kim | Director, Executive |
| Sang Gyun Kim | Director |
| Joo Hee Kwak | Director |
| Heewon Park | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
134 Coolidge Avenue Biolabs 2 Nd Floor
Watertown, MA, 02472
Watertown, MA, 02472